Along these lines, further experiments on in vivo transgenic mice could be useful to understand whether the presence of a functional EZH2 is crucial to protect the liver from diet-induced NAFLD, as well as to develop potential targeted-preventive strategies. This evidence concerns the gene EZH2 and metabolic dysfunction-associated steatotic liver disease.